Literature DB >> 27782329

Complement in removal of the dead - balancing inflammation.

Myriam Martin1, Anna M Blom2.   

Abstract

Recognition and removal of apoptotic and necrotic cells must be efficient and highly controlled to avoid excessive inflammation and autoimmune responses to self. The complement system, a crucial part of innate immunity, plays an important role in this process. Thus, apoptotic and necrotic cells are recognized by complement initiators such as C1q, mannose binding lectin, ficolins, and properdin. This triggers complement activation and opsonization of cells with fragments of C3b, which enhances phagocytosis and thus ensures silent removal. Importantly, the process is tightly controlled by the binding of complement inhibitors C4b-binding protein and factor H, which attenuates late steps of complement activation and inflammation. Furthermore, factor H becomes actively internalized by apoptotic cells, where it catalyzes the cleavage of intracellular C3 to C3b. The intracellularly derived C3b additionally opsonizes the cell surface further supporting safe and fast clearance and thereby aids to prevent autoimmunity. Internalized factor H also binds nucleosomes and directs monocytes into production of anti-inflammatory cytokines upon phagocytosis of such complexes. Disturbances in the complement-mediated clearance of dying cells result in persistence of autoantigens and development of autoimmune diseases like systemic lupus erythematosus, and may also be involved in development of age-related macula degeneration.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  apoptosis; clearance; complement system; factor H; intracellular complement; systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 27782329     DOI: 10.1111/imr.12462

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  44 in total

Review 1.  Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.

Authors:  Daniel Ricklin; Edimara S Reis; Dimitrios C Mastellos; Piet Gros; John D Lambris
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

Review 2.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  Cigarette smoke-induced reduction of C1q promotes emphysema.

Authors:  Xiaoyi Yuan; Cheng-Yen Chang; Ran You; Ming Shan; Bon Hee Gu; Matthew C Madison; Gretchen Diehl; Sarah Perusich; Li-Zhen Song; Lorraine Cornwell; Roger D Rossen; Rick Wetsel; Rajapakshe Kimal; Cristian Coarfa; Holger K Eltzschig; David B Corry; Farrah Kheradmand
Journal:  JCI Insight       Date:  2019-05-21

4.  Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.

Authors:  Ciro Romano; Andrea Del Mastro; Ausilia Sellitto; Eleonora Solaro; Sergio Esposito; Giovanna Cuomo
Journal:  Clin Rheumatol       Date:  2018-01-23       Impact factor: 2.980

Review 5.  The many ways tissue phagocytes respond to dying cells.

Authors:  J Magarian Blander
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

Review 6.  The complement system as a potential therapeutic target in rheumatic disease.

Authors:  Leendert A Trouw; Matthew C Pickering; Anna M Blom
Journal:  Nat Rev Rheumatol       Date:  2017-08-10       Impact factor: 20.543

Review 7.  The renaissance of complement therapeutics.

Authors:  Daniel Ricklin; Dimitrios C Mastellos; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

Review 8.  Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets.

Authors:  Andrea J Tenner
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 9.  How macrophages deal with death.

Authors:  Greg Lemke
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

10.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.